The items on the agenda of the ordinary and extraordinary general shareholders' meetings include the proposed approval of a number of resolutions relating ...
Recorded Q1'23 consolidated revenue of KRW 720.9 billion. Recorded Q1'23 consolidated operating profit of KRW 191.7 billion. Expected to main...
Revenue Up 5.8% Year-Over-Year to RMB8,964 MillionNet Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year to RMB2,168 MillionDiluted ...
Adcentrx Therapeutics ("Adcentrx"), a biotechnology company dedicated to revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other li...
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) (“Vallon” or the “Company”) today announced that its stockholders have approved Proposa...
Aptitude Medical Systems (Aptitude™) announced today that it has received an award up to $53.7 million from Biomedical Advanced Research and Developm...
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its res...
Co-founded by acclaimed oncologist Dennis Slamon, M.D., Ph.D., of University of California at Los Angeles (UCLA) and entrepreneur and CEO David Licata, a...
Nicox’s partner, Ocumension Therapeutics, submits a New Drug Application for ZERVIATE in China ZERVIATE® approval and launch expected ...
To participate, call 833-470-1428 within the U.S. or +1 929-526-1599 outside the U.S., access code: 522530. A live webcast of the conference call will also...
Samsung Ventures makes investment in Araris Proceeds will be used to support further development and advancement of Araris’ antibody-drug conjugat...
The loan carries 10% simple interest, may be prepaid without penalty, is extendable for an additional six months and includes warrants to purchase 390,000 ...
GSK4532990 is being developed under the November 2021 exclusive license agreement between Arrowhead and GSK. GSK received an exclusive license to develop a...
The oversubscribed financing was led by Novalis LifeSciences, with participation from Sozo Ventures, Hatteras Venture Partners, iSelect Fund, American Canc...
© 2024 Biopharma Boardroom. All Rights Reserved.
